(Q54383848)

English

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

George Fountzilas

15

object named as

George Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

5

object named as

Ralph M Wirtz

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Anastasia G Eleftheraki

7

object named as

Anastasia G Eleftheraki

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Dimitrios Pectasides

8

object named as

Dimitrios Pectasides

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Angelos Koutras

13

object named as

Angelos K Koutras

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

George Pentheroudakis

1

object named as

George Pentheroudakis

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Konstantine T Kalogeras

3

object named as

Konstantine T Kalogeras

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

12

object named as

Helen Gogas

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Nicholas Pavlidis

14

object named as

Nicholas Pavlidis

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Anna Batistatou

2

object named as

Anna Batistatou

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Evangelos Bournakis

6

object named as

Evangelos Bournakis

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

author name string

Ralf Kronenwett

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Irini Papaspirou

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Sevasti Kamina

11

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

language of work or name

0 references

publication date

9 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

127

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

179-193

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

https://scigraph.springernature.com/pub.10.1007/s10549-011-1427-0

0 references

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Microtubule-associated proteins as targets in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Microtubules, microtubule-interfering agents and apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Microtubules and resistance to tubulin-binding agents

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Microtubules as a target for anticancer drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Molecular biology and genetics of tubulin.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

In vivo microtubules are copolymers of available beta-tubulin isotypes: localization of each of six vertebrate beta-tubulin isotypes using polyclonal antibodies elicited by synthetic peptide antigens

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Mechanisms of Taxol resistance related to microtubules.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Cloning and characterization of the 5'-flanking region of the rat neuron-specific Class III beta-tubulin gene

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

The role of the miR-200 family in epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

The RNA continent

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1427-0

21 January 2018

Identifiers

10.1007/S10549-011-1427-0

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21390496

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54383848&oldid=1835181427"